Comparison
1q44 Microdeletion Syndrome C4304540 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 1q44 Microdeletion Syndrome and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
1q44 Microdeletion Syndrome C4304540
A rare chromosomal abnormality affecting chromosome 1. Causes developmental delays, intellectual disability, and brain abnormalities. Management is supportive and symptom-focused.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
1q44 Microdeletion Syndrome C4304540
0-null
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
1q44 Microdeletion Syndrome C4304540
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
1q44 Microdeletion Syndrome C4304540
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
1q44 Microdeletion Syndrome C4304540
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
1q44 Microdeletion Syndrome C4304540
congenital
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
1q44 Microdeletion Syndrome C4304540
rare-disease
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
1q44-microdeletion-syndrome-C4304540 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q44 Microdeletion Syndrome C4304540 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Developmental profile | Delays with intellectual disability and described brain abnormalities. | Delays, learning difficulties, and sometimes autism-spectrum traits. | Moderate |
| Chromosomal change | Microdeletion involving chromosome 1q44. | Microduplication of chromosome 15q11q13, a Prader-Willi/Angelman-linked region. | High |
| Reported severity and onset | Supplied severity is severe; onset is not established. | Supplied severity is moderate, with onset described from birth to age 3. | Moderate |
When to favor each condition
Choose 1q44 Microdeletion Syndrome C4304540 when
Confirmed 1q44 deletion
The chromosomal result directly identifies this syndrome rather than a 15q duplication.
High
Severe impairment with brain abnormality
This pattern fits the supplied description, but genotype confirmation remains necessary.
Moderate
Counseling after chromosome 1 testing
Management and recurrence discussion should follow the confirmed deletion.
Moderate
Choose 15q11q13 Microduplication Syndrome C2675336 when
Confirmed 15q11q13 duplication
A duplication in this region distinguishes it from a 1q44 deletion.
High
Learning difficulty or autism traits
These features are described, but they are not specific without genetic confirmation.
Moderate
Concern about Prader-Willi or Angelman region
The shared region warrants testing, but duplication is not either syndrome by itself.
Moderate
How key tests differ
| Test | 1q44 Microdeletion Syndrome C4304540 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss at 1q44. | Copy-number gain at 15q11q13. | A confirmed result best distinguishes the conditions; clinician review is required. |
| Karyotype or targeted FISH | May miss a small 1q44 deletion. | May miss a small 15q11q13 duplication. | Normal results do not exclude either micro-change. |
| Neurodevelopmental assessment | Documents delay, disability, and neurologic findings. | Documents learning, development, and possible autism traits. | Assessment guides support but cannot establish the chromosomal diagnosis. |
Prognosis comparison
1q44 Microdeletion Syndrome C4304540
- Outcome
- Chronic course with potentially severe developmental impact; survival and function are not quantified here.
- Factors
- Deletion extent, brain findings, seizures, and comorbidities may matter, but effects are not established.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Chronic course often described as moderate, with variable learning and behavioral needs.
- Factors
- Duplication size, neurodevelopment, autism traits, and support access may influence function.
Time frame: Lifelong, with needs changing through childhood and adulthood.
Confirmed genotype, early therapies, comorbidities, and individualized educational support.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Intellectual disability and developmental delay are described. Developmental delay and learning difficulty are described. Range and severity vary; no outcome rates are established here. |
| Brain structure | Brain abnormalities are part of the supplied description. Structural brain findings are not established by the supplied data. Imaging abnormalities need individual clinician interpretation. |
| Behavior | A specific behavioral profile is not established here. Autism-spectrum traits may occur but are not universal. Behavioral findings do not replace genetic confirmation. |
Patient education highlights
- HighConfirmation
Ask which chromosome and whether material is missing or duplicated; similar symptoms can have different causes.
- HighCare
Both are managed supportively, with therapies matched to development, learning, behavior, and neurologic needs.
- MediumInheritance and infection
Neither is communicable. Inheritance and recurrence require genetics review and are not established here.